Accessibility Tools

Clinical Guidelines & Pathways


GLP-1 agonist Prescribing Guideline


Minor update Dec 2022

View Document

Guideline Categories: Endocrinology and Diabetes

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: dulaglutide, Glucagon-like peptide 1 (GLP 1) agonists, liraglutide, semaglutide, type 2 diabetes

Please use the search box to search the whole site if you can't find what you're looking for:

To top
Welcome to the BLMK Medicines Optimisation website.
This site is currently being updated.

If you have any feedback or find any issues, please email the team:
BLMKICB.MedsOpt@nhs.net